Relationship between renal capacity to reabsorb glucose and renal status in patients with diabetes

Blantz, 1982, Effect of modest hyperglycemia on tubuloglomerular feedback activity, Kidney Int Suppl, 12, S206 Vallon, 2002, Salt-sensitivity of proximal reabsorption alters macula densa salt and explains the paradoxical effect of dietary salt on glomerular filtration rate in diabetes mellitus, J Am Soc Nephrol, 13, 1865, 10.1097/01.ASN.0000016441.41118.57 Brenner, 1996, The hyperfiltration theory: a paradigm shift in nephrology, Kidney Int, 49, 1774, 10.1038/ki.1996.265 Carpentier, 2019, Glycosuria amount in response to hyperglycaemia and risk for diabetic kidney disease and related events in type 1 diabetic patients, Nephrol Dial Transplant, 34, 1731, 10.1093/ndt/gfy197 Wanner, 2016, Empagliflozin and progression of kidney disease in type 2 diabetes, N Engl J Med, 375, 1801, 10.1056/NEJMoa1515920 Neal, 2017, Canagliflozin and cardiovascular and renal events in type 2 diabetes, N Engl J Med, 377, 644, 10.1056/NEJMoa1611925 Wiviott, 2019, Dapagliflozin and cardiovascular outcomes in type 2 diabetes, N Engl J Med, 380, 347, 10.1056/NEJMoa1812389 Smyth, 2019, Genetic associations between genes in the renin-angiotensin-aldosterone system and renal disease: a systematic review and meta-analysis, BMJ Open, 9, e026777, 10.1136/bmjopen-2018-026777 Marre, 1997, Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group, J Clin Invest, 99, 1585, 10.1172/JCI119321 Mohammedi, 2013, Catalase activity, allelic variations in the catalase gene and risk of kidney complications in patients with type 1 diabetes, Diabetologia, 56, 2733, 10.1007/s00125-013-3057-z Velho, 2013, Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria, Diabetes Care, 36, 3639, 10.2337/dc13-0683 Patente, 2015, Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes, Free Radic Biol Med, 86, 16, 10.1016/j.freeradbiomed.2015.04.002 Velho, 2015, Plasma adrenomedullin, allelic variation in the ADM gene and kidney disease in people with type 2 diabetes, Diabetes, 64, 3262, 10.2337/db14-1852 Velho, 2016, Plasma copeptin, kidney outcomes, ischemic heart disease, and all-cause mortality in people with long-standing type 1 diabetes, Diabetes Care, 39, 2288, 10.2337/dc16-1003 Sandholm, 2017, The genetic landscape of renal complications in type 1 diabetes, J Am Soc Nephrol, 28, 557, 10.1681/ASN.2016020231 Sanchez, 2018, Plasma concentrations of 8-hydroxy-2’-deoxyguanosine and risk of kidney disease and death in individuals with type 1 diabetes, Diabetologia, 61, 977, 10.1007/s00125-017-4510-1 van Zuydam, 2018, A genome-wide association study of diabetic kidney disease in subjects with type 2 diabetes, Diabetes, 67, 1414, 10.2337/db17-0914 Skupien, 2019, Variations in risk of end-stage renal disease and risk of mortality in an international study of patients with type 1 diabetes and advanced nephropathy, Diabetes Care, 42, 93, 10.2337/dc18-1369 Cherney, 2014, Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus, Circulation, 129, 587, 10.1161/CIRCULATIONAHA.113.005081 Bonnardeaux, 2004, Inherited disorders of the renal tubule, 1714 Levey, 2009, A new equation to estimate glomerular filtration rate, Ann Intern Med, 150, 604, 10.7326/0003-4819-150-9-200905050-00006 2013, Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease, Kidney Int Suppl, 3, 1 Ninomiya, 2009, Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes, J Am Soc Nephrol, 20, 1813, 10.1681/ASN.2008121270 Najafian, 2011, Pathology of human diabetic nephropathy, Contrib Nephrol, 170, 36, 10.1159/000324942 Wright, 2011, Biology of human sodium glucose transporters, Physiol Rev, 91, 733, 10.1152/physrev.00055.2009 Santer, 2003, Molecular analysis of the SGLT2 gene in patients with renal glucosuria, J Am Soc Nephrol, 14, 2873, 10.1097/01.ASN.0000092790.89332.D2 Pontoglio, 2000, HNF-1a controls renal glucose reabsorption in mouse and man, EMBO Rep, 1, 359, 10.1093/embo-reports/kvd071 Bhargava, 2017, Mitochondrial energetics in the kidney, Nat Rev Nephrol, 13, 629, 10.1038/nrneph.2017.107 Coughlan, 2016, Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes, Clin Sci (Lond), 130, 711, 10.1042/CS20150838 Mohammedi, 2014, Manganese superoxide dismutase (SOD2) polymorphisms, plasma advanced oxidation protein products (AOPP) concentration and risk of kidney complications in subjects with type 1 diabetes, PloS one, 9, e96916, 10.1371/journal.pone.0096916 Mohammedi, 2011, Allelic variations in superoxide dismutase-1 (SOD1) gene are associated with increased risk of diabetic nephropathy in type 1 diabetic subjects, Mol Genet Metab, 104, 654, 10.1016/j.ymgme.2011.08.033 Mohammedi, 2016, Glutathione peroxidase-1 gene (GPX1) variants, oxidative stress and risk of kidney complications in people with type 1 diabetes, Metabolism, 65, 12, 10.1016/j.metabol.2015.10.004 Monteiro, 2013, Sex-specific associations of variants in regulatory regions of NADPH oxidase-2 (CYBB) and glutathione peroxidase 4 (GPX4) genes with kidney disease in type 1 diabetes, Free Radic Res, 47, 804, 10.3109/10715762.2013.828347